Department of Plastic and Reconstructive Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.
J Craniofac Surg. 2023;34(8):e733-e736. doi: 10.1097/SCS.0000000000009499. Epub 2023 Jul 10.
This study aimed to introduce the use of an acellular dermal matrix (ADM) as a posterior lamellar substitution for full-thickness eyelid reconstruction after malignant tumor excision. After resection of the malignant eyelid tumors, anterior lamellar defects were repaired using direct sutures and pedicled flaps in 20 patients (15 men and 5 women). ADM was used to replace the tarsal plate and the conjunctiva. All patients were followed up for 6 months or more to assess the functional and esthetic outcomes of the procedure. The flaps survived in all but 2 cases, wherein they necrosed due to insufficient blood supply. The functionality and esthetic outcomes were excellent in 10 and 9 patients, respectively. There were no changes in visual acuity or corneal epithelial damage after the surgery. The eyeball movement was good. Corneal irritation no longer appeared, and patient comfort was maintained. Furthermore, no tumor recurrence occurred in any patient. ADM is a valuable posterior lamellar material for the full-thickness reconstruction of eyelid defects after the resection of malignant tumors on the eyelids.
本研究旨在介绍脱细胞真皮基质（ADM）在后层替代全层眼睑重建中的应用，用于恶性肿瘤切除术后的全层眼睑重建。在切除恶性眼睑肿瘤后，20 名患者（15 名男性和 5 名女性）采用直接缝合和带蒂皮瓣修复前层缺损。ADM 用于替代睑板和结膜。所有患者均随访 6 个月或更长时间，以评估手术的功能和美容效果。除 2 例因血供不足导致皮瓣坏死外，其余皮瓣均存活。10 例患者的功能和美容效果均良好，9 例患者的功能和美容效果均良好。术后视力或角膜上皮损伤无变化。眼球运动良好。角膜刺激不再出现，患者舒适度得以维持。此外，患者无一例肿瘤复发。ADM 是一种有价值的后层材料，可用于全层重建眼睑恶性肿瘤切除术后的眼睑缺损。
